Jin Medical International reported asset growth of 15.08% for the quarter ended Mar 2026. These growth metrics cover 6 quarters of results from Sep 2023 through Mar 2026, standardized by Business Quant from the company’s SEC filings.
| Growth Metrics | Sep2023 | Mar2024 | Sep2024 | Mar2025 | Sep2025 | Mar2026 |
|---|---|---|---|---|---|---|
| Growth Ratios | ||||||
| Assets Growth (1y) | 57.14% | 32.68% | 39.20% | 17.89% | 16.52% | 15.08% |
| Assets Growth (3y) | 36.60% | 21.64% | ||||
| Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y) | 44.59% | 2.20% | 17.41% | 25.43% | -8.29% | -18.40% |
| Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y) | 15.90% | 1.51% | ||||
| Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y) | -9.04% | 92,509,741.09% | -1.39% | 127.97% | -100.00% | -100.00% |
| Property, Plant & Equipment (Net) Growth (3y)PP&E (Net) Growth (3y) | -98.31% | 83.94% | ||||
| Total Debt Growth (1y) | 664,914,713.27% | 175.28% | 62.45% | -100.00% | -100.00% | |
| Total Debt Growth (3y) | 142.82% |